ResearchPeptide

Mazdutide

Published Research

PubMed-indexed studies for Mazdutide

Research

Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial.

EClinicalMedicine 2022

View on PubMed →

Research

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.

The New England journal of medicine 2025

View on PubMed →

Research

Novel GLP-1-based Medications for Type 2 Diabetes and Obesity.

Endocrine reviews 2026

View on PubMed →

Research

Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.

Metabolism: clinical and experimental 2024

View on PubMed →

Research

Emerging pharmacotherapies for obesity: A systematic review.

Pharmacological reviews 2025

View on PubMed →

Research

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?

Expert opinion on pharmacotherapy 2024

View on PubMed →

Research-Grade Mazdutide

YPB.269

Mazdutide (100mg)

$180.00

⚠️ For laboratory research only. Not for human use.

Mazdutide

Published Research

Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial.

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.

Novel GLP-1-based Medications for Type 2 Diabetes and Obesity.

Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.

Emerging pharmacotherapies for obesity: A systematic review.

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?

Research-Grade Mazdutide

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

Published Research

Safety and efficacy of a GLP-1 and glucagon receptor dual agonist mazdutide (IBI362) 9 mg and 10 mg in Chinese adults with overweight or obesity: A randomised, placebo-controlled, multiple-ascending-dose phase 1b trial.

Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight.

Novel GLP-1-based Medications for Type 2 Diabetes and Obesity.

Seven glucagon-like peptide-1 receptor agonists and polyagonists for weight loss in patients with obesity or overweight: an updated systematic review and network meta-analysis of randomized controlled trials.

Emerging pharmacotherapies for obesity: A systematic review.

Oral glucagon-like peptide-1 receptor agonists and combinations of entero-pancreatic hormones as treatments for adults with type 2 diabetes: where are we now?

Research-Grade Mazdutide

Frequently Asked Questions

What are research peptides?

What does peptide purity mean and why does it matter?

What form do your peptides come in?

How should research peptides be stored?

Who can purchase research peptides?

How do you ensure peptide quality?

What does "Research Use Only" mean?

How are peptides shipped?

What is your return and refund policy?

⚠️ Research Use Only — Legal Acknowledgment